GlaxoSmithKline 4Q Revenues: $12.1 billion (+5%) 4Q Earnings: $2.2 billion (-6%) FY Revenues: $45.4 billion (+6%) FY Earnings: $10.6 billion (+4%)   Comments: Advair sales were $7.0 billion for the year (+15%) and $1.9 billion in the quarter (+12%). Lamictal sales were $2.2 billion for the year (+22%) and $610 million in the quarter (+22%). Avandia sales dropped 31% to $1.8 billion for the year, and $327 million in the quarter (-48%), due to reports that linked the drug to an incr...